Battle Over Opioids: Surprising Push-Back, and Not From Dealers
If you thought tighter restrictions were helping to solve the opioid crisis, think again. Some patients, pain doctors, and groups are pushing back.
Green-Blooded Lizards May Hold Key to New Virus Fighters
The peculiar amphibian is somehow impervious to lethal levels of a jaundice-causing toxin — the pigment responsible for its green color.
Group With Ties to Trump Opioid Chief Scores Big
A small group with ties to President Donald Trump’s opioid czar has just been awarded $24 million in federal grants.
Would You Be a Human Guinea Pig for the Koch Brothers?
In his State of the Union address, President Donald Trump urged Congress to pass a controversial bill promising greater access to untested drugs for terminally ill patients. But critics charge the bill would only deliver false hope and result in even less patient protection by removing FDA oversight.
Banned Seven Words: Censorship or Good Strategy?
After a federal official told staff not to use certain words in budget documents, the pushback was huge. But there might have been a method to this madness.
Will Controversial Bill Cure or Kill Patients?
“Right to Try” legislation would allow pharmaceutical companies to give experimental drugs to desperate patients — with no chance of being liable if things go wrong. Supporters of the measure cheer this approach but critics see dangers.
Ebola, We Hardly Knew You: 3 Lessons from the Hysteria
Now that ebola hysteria has stopped interrupting regular programming and the American patients are cured, the risk is gone, right? Not so fast …